Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Restructuring Costs (2021 - 2025)

Cellebrite DI's Restructuring Costs history spans 5 years, with the latest figure at $164000.0 for Q3 2025.

  • Quarterly Restructuring Costs fell 22.64% to $164000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $385000.0 through Sep 2025, up 18.46% year-over-year, with the annual reading at $221000.0 for FY2024, 391.11% up from the prior year.
  • Restructuring Costs came in at $164000.0 for Q3 2025, down from $212000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.2 million in Q4 2021 to a low of -$323000.0 in Q2 2023.
  • The 5-year median for Restructuring Costs is $188000.0 (2024), against an average of $297250.0.
  • Year-over-year, Restructuring Costs plummeted 181.98% in 2023 and then soared 307.69% in 2024.
  • Cellebrite DI's Restructuring Costs stood at $1.2 million in 2021, then crashed by 88.7% to $133000.0 in 2022, then plummeted by 60.9% to $52000.0 in 2023, then surged by 307.69% to $212000.0 in 2024, then decreased by 22.64% to $164000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Restructuring Costs are $164000.0 (Q3 2025), $212000.0 (Q3 2024), and $9000.0 (Q1 2024).